MEENAKSHI IYER
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism SUWANEE, GA NPI 1982736674
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism GA Xeris Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$16,433.08
- Category: General Payments
- Program years: PY2018–2024
- Record count: 340
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,246.94 across 60 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,226.94 | 59 |
| Education | $20.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | $214.59 | 10 |
| Novo Nordisk AS | $153.61 | 12 |
| Amgen Inc. | $88.10 | 4 |
| Lilly USA, LLC | $81.66 | 4 |
| Insulet Corporation | $71.80 | 3 |
| CeQur Corporation | $71.74 | 1 |
| SANOFI-AVENTIS U.S. LLC | $63.49 | 2 |
| Ascensia Diabetes Care US Inc. | $62.52 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $61.19 | 3 |
| Corcept Therapeutics | $56.94 | 2 |
| MannKind Corporation | $54.15 | 3 |
| Tandem Diabetes Care, Inc. | $51.52 | 3 |
| PFIZER INC. | $43.26 | 2 |
| IBSA Pharma Inc. | $40.56 | 1 |
| Antares Pharma, Inc. | $30.73 | 2 |
| DEXCOM, INC. | $24.13 | 1 |
| VIVUS LLC | $21.12 | 1 |
| Ascendis Pharma Inc | $20.36 | 1 |
| Amneal Pharmaceuticals LLC | $19.47 | 1 |
| ABBVIE INC. | $16.00 | 1 |
By program year
Records — PY2024 (60)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.